YKL‐40 is a proposed biomarker of inflammation and remodelling elevated in children with bronchopulmonary dysplasia compared to asthma

Detalles Bibliográficos
Autores principales: James, Anna J., Nordlund, Björn, Konradsen, Jon R., Ebersjö, Christina, Dahlén, Sven‐Erik, Berggren Broström, Eva, Hedlin, Gunilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Regular Articles & Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891389/
https://www.ncbi.nlm.nih.gov/pubmed/32772428
http://dx.doi.org/10.1111/apa.15525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891389/
https://www.ncbi.nlm.nih.gov/pubmed/32772428
http://dx.doi.org/10.1111/apa.15525

Ejemplares similares